Trump Vows to Slash the Cost of Prescription Drugs in Future Administration

Former President Donald Trump has pledged to dramatically reduce the cost of prescription drugs if re-elected. Citing his previous efforts to confront pharmaceutical companies, Trump promises to implement a “Most Favored Nation” pricing strategy that would tie U.S. drug prices to the lowest prices paid by other developed nations. This bold proposal aims to cut drug costs by up to 80%, eliminate price-gouging by middlemen, and make life-saving medications more affordable for all Americans. As the debate over healthcare intensifies, Trump’s vow signals a renewed focus on lowering out-of-pocket expenses and reforming Big Pharma practices.

Trump, prescription drugs, drug prices, healthcare, Most Favored Nation policy, MFN pricing, pharmaceutical costs, executive order, Big Pharma, drug reform, Trump 2025 plan, healthcare reform, lower drug costs, medication prices, U.S. healthcare, drug price cuts, middlemen, pharmacy benefit managers, PBMs, healthcare savings, Trump administration, Trump campaign promise, affordable medicine, pharmaceutical policy, price transparency, Trump healthcare plan, drug affordability, Medicare drugs, drug pricing policy, HHS, Trump vow, pharmaceutical reform, Trump news, Trump 2025 healthcare, prescription savings, drug price reduction, cost control, Trump promises, healthcare costs, healthcare initiative, drug legislation, medication reform, election promises, prescription cost relief, patient savings, Trump healthcare strategy, healthcare campaign, prescription price cuts, medical expenses, Trump vs. Big Pharma, prescription drug overhaul, Medicare negotiation, policy change, Trump speech, election healthcare policy, healthcare action plan, regulatory reform, drug supply chain, healthcare platform, medicine affordability, drug costs 2025, Trump reforms, cost-cutting policy, drug importation, patient costs, healthcare impact, Trump proposals, Trump policy update, Trump campaign 2025, prescription drug access, American healthcare system, healthcare affordability, drug price policy, economic reform, cost-saving measures, healthcare news, health policy changes, medication pricing, healthcare overhaul, pharmaceutical innovation, Trump legislation, prescription drug industry, healthcare market reform, election healthcare issue, Trump policy agenda, pharmaceutical control, medical cost reform, drug market shift, health system reform, policy enforcement, 2025 election issues, healthcare goals, economic fairness, drug industry changes, access to medicine, affordable care, prescription expense.